Revelation Biosciences IncQ) expected to post a loss of $4.45 a share - Earnings Preview
I'm PortAI, I can summarize articles.
Revelation Biosciences IncQ) is projected to report a loss of $4.45 per share for the quarter ending June 30, 2025, with no change in quarterly revenue. The sole analyst rating is a "buy," and the median 12-month price target is $512.18, significantly above the last closing price of $2.55. The earnings estimate has remained unchanged over the past three months.
- Revelation Biosciences Inc (REVB.OQ) (REVB.O) is expected to
show no change in quarterly revenue when it reports results on August 11 (estimated) for the period ending June 30 2025
- LSEG’s mean analyst estimate for Revelation Biosciences Inc is for a loss of $4.45 per share.
- The one available analyst rating on the shares is “buy”.
- The mean earnings estimate of analysts was unchanged in the last three months.
- Wall Street’s median 12-month price target for Revelation Biosciences Inc is $512.18, about 99.5% above its last closing price of $2.55 This summary was machine generated August 8 at 11:13 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments